Related Experiment Video
Updated: Aug 6, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Protective effect of overweight status in aortic valve surgery: revisiting the obesity paradox
Harrison Feerst1, Mehrtash Hashemzadeh1, Mohammad Reza Movahed1,2
1Department of Medicine, University of Arizona Phoenix, AZ, USA.
Objectives:
To investigate the relationship between body mass index (BMI) and postoperative mortality in patients undergoing aortic valve surgery, with an emphasis on exploring the presence and limits of the "obesity paradox", the phenomenon wherein overweight and mildly obese patients may experience lower mortality despite obesity's general association with adverse health outcomes.
Methods:
The Nationwide Inpatient Sample (NIS) database was used to obtain data from adult patients who underwent aortic valve surgery between 2016 and 2020. BMI categories, as well as comorbidities, were identified using ICD-10 codes. Mortality rates across BMI categories were compared, and multivariate analysis was performed to adjust for comorbid conditions. This is a retrospective observational study.
Results:
We found 301,250 adult patients who underwent aortic valve surgery. Normal weight patients (n=226,490) had a mortality rate of 3.79%. Overweight (n=2,555) and obese (n=46,320) patients demonstrated significantly lower mortality rates of 1.17% (OR=0.30, 95% CI: 0.14-0.66; P=0.003) and 2.43% (OR=0.63, 95% CI: 0.55-0.73; P<0.001), respectively. Cachectic patients (n=835) had the highest mortality rate at 14.97% (OR=4.47, 95% CI: 2.87-6.96; P<0.001). Morbidly obese patients (n=25,450) had a mortality rate of 4.13%, which was not significantly different from normal-weight patients (OR=1.09, 95% CI: 0.94-1.26; P=0.23). These trends and statistical significance remained after multivariate logistic regression, accounting for demographics and comorbidities.
Conclusions:
The partial obesity paradox is true in patients undergoing aortic valve surgery, with the lowest mortality occurring in overweight patients, followed by obese patients, and with cachexia having the highest mortality out of all groups.
Related Concept Videos
Drug Dosing: Obese Patients
Aortic Regurgitation III: Medical Management
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Aortic Regurgitation I: Introduction